Treatment of vasculitis.
1993; Wiley; Volume: 35; Issue: 2 Linguagem: Inglês
10.1111/j.1365-2125.1993.tb05674.x
ISSN1365-2125
Autores Tópico(s)Kawasaki Disease and Coronary Complications
ResumoBritish Journal of Clinical PharmacologyVolume 35, Issue 2 p. 93-104 Free Access Treatment of vasculitis. HG Taylor, HG Taylor Department of Rheumatology, Leicester Royal Infirmary.Search for more papers by this authorA. Samanta, A. Samanta Department of Rheumatology, Leicester Royal Infirmary.Search for more papers by this author HG Taylor, HG Taylor Department of Rheumatology, Leicester Royal Infirmary.Search for more papers by this authorA. Samanta, A. Samanta Department of Rheumatology, Leicester Royal Infirmary.Search for more papers by this author First published: Feb 1993 https://doi.org/10.1111/j.1365-2125.1993.tb05674.xCitations: 14AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References Aktulga, A., Altac, M., Muftuoglu, A. U., Ozyazgan, Y. & Payarli, H. A. (1980). A double blind study of colchicine in Behcet's disease. Haematologica, 65, 399– 402. Alarcon-Segovia, D. (1977). The necrotizing vasculitides: a new pathogenetic classification. Med. Clin. North. Am., 61, 241– 260. Allison, M. C. & Gallagher, P. J. (1984). Temporal artery biopsy and cortisteroid treatment. Ann. Rheum. Dis., 43, 416– 417. Al-Safi, S. A. & Maddocks, J. L. (1983). The effects of azathioprine on the human mixed lymphocyte reaction (MLR). Br. J. clin. Pharmac., 15, 203– 209. Al-Safi, S. A. & Maddocks, J. L. (1984). Azathioprine and 6-mercaptopurine suppress the human mixed lymphocyte reaction by different mechanisms. Br. J. clin. Pharmac., 17, 417– 422. American Medical Association Panel on Therapeutic Plasmapheresis. (1985). Current status of therapeutic plasmapheresis and related techniques. J. Am. med. Ass., 253, 819– 825. Andersson, R., Rundgren, A., Rosengren, K., Bengtsson, B-A., Malmvall, B-E. & Mellstroom, D. (1990). Osteoporosis after long-term corticosteroid treatment of giant cell arteritis. J. int. Med., 227, 391– 395. Asherson, R. A., D'Cruz, D., Stephens, C. J., McKee, P. H. & Hughes, G. R. (1991). Urticarial vasculitis in a connective tissue disease clinic: patterns, presentations and treatment. Semin. Arthritis Rheum., 20, 285– 296. Austin, H. A., III, Klippel, J. H., Balow, J. E., Le Riche, N. G., Steinberg, A. D., Plotz, P. H. & Decker, J. L. (1986). Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. New Engl. J. Med., 314, 614– 619. Axelson, J. A., Clark, R. H. & Ancerewicz, S. (1987). Wegener's granulomatosis and trimethoprim-sulphamethoxazole. Ann. Intern. Med., 107, 600. Bagley, C. M., Bostick, F. W. & De Vita, V. T. Jr. (1973). Clinical pharmacology of cyclophosphamide. Cancer Res., 33, 226– 233. Baguley, E. & Hughes, G. R. V. (1988). Lytic antiendothelial cell antibodies. Lancet, ii, 907. Baguley, E. & Hughes, G. R. V. (1989). Antiendothelial cell antibodies. J. Rheumatol., 16, 716– 717. Balow, J. E., Austin III, H. A., Meunz, L. R., Joyce, K. M., Antonovych, T. T., Klippel, J. H., Steinberg, A. D., Plotz, P. H. & Decker, J. L. (1984). Effect of treatment on the evolution of renal abnormalities in lupus nephritis. New Engl. J. Med., 311, 491– 495. Bernard, P., Arnaud, M., Treves, R. & Bonnetblanc, J. M. (1988). Dapsone and rheumatoid vasculitis leg ulcerations. J. Am. Acad. Dermatol., 18, 140– 141. Bertino, J. R. (1973). Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man. Arthritis Rheum., 16, 79– 83. Blackwell, G. J., Carnuccio, R., DiRosa, M., Flower, R. J., Parente, L. & Persico, P. (1980). Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature, 287, 147– 149. Boom, B. W., Brand, A., Bavinck, J. N., Eernisse, J. G., Daha, M. R. & Vermeer, B. J. (1988). Severe leukocyto-clastic vasculitis of the skin in a patient with essential mixed cryoglobulinaemia treated with high dose gammaglobulin intravenously. Arch. Dermatol., 124, 1550– 1553. Boumpas, D. T., Paliogianni, F., Anastassiou, E. D. & Balow, J. E. (1991). Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin. exp. Rheumatol., 9, 413– 423. Brandwein, S., Esdaille, J., Danhoff, D. & Tannenbaum, H. (1983). Wegener's granulomatosis. Clinical features and outcome in 13 patients. Arch. intern. Med., 143, 476– 479. Brockman, R. W. (1963). Biochemical aspects of mercaptopurine inhibition and resistance. Cancer Res., 23, 1191– 1201. Butler, W. T. & Rossen, R. D. (1973). Effects of corticosteroids on immunity in man I. Decreased IgG concentrations caused by 3 or 5 days of high doses of methylprednisolone. J. clin. Invest., 52, 2629– 2640. Calabresi, P. & Parks, R. E. (1985). Antiproliferative agents and drugs used for immunosuppression. In Goodman and Gilman's The Pharmacologic Basis of Therapeutics 7th ed, eds A. G. Gilman, L. S. Goodman, T. W. Rall & F. Murad, pp. 1247– 1306. New York : MacMillan Publishing Company.. Calamia, K. T. & Hunder, G. G. (1980). Clinical manifestations of giant cell arteritis. Clin. Rheum. Dis., 6, 389– 403. Callen, J. P. & Ekenstam, E. (1987). Cutaneous leukocytoclastic vasculitis: clinical experience in 44 patients. South. med. J., 80, 848– 851. Cameron, J. S. (1988). Acute renal disease in vasculitis. Ann. Med. Intern., 139, 103– 108. Cameron, J. S., Turner, D. R., Ogg, C. S., Williams, D. G., Lessof, M. H., Chantler, C. & Leibowitz, S. (1979). Systemic lupus with nephritis: a long term study. Quart. J. Med., 48, 1– 24. Carette, S., Klippel, J. H., Decker, J. L., Austin, H. A., Plotz, P. H., Steinberg, A. D. & Balow, J. E. (1983). Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long term follow up. Ann. Intern. Med., 99, 1– 8. Chow, C. C., Li, E. K. M. & Mac-Moune Lai, F. (1989). Allergic granulomatosis and angiitis (Churg-Strauss syndrome): response to ‘pulse’ intravenous cyclophosphamide. Ann. Rheum. Dis., 48, 605– 608. Chumbley, L. C., Harrison, R. A. & DeRemee, R. A. (1977). Allergic granulomatous angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin. Proc., 52, 477– 484. Claman, H. N. (1972). Corticosteroids and lymphoid cells. New Engl. J. Med., 287, 388– 397. Clements, P. J. & Davis, J. (1986). Cytotoxic drugs: Their clinical application to the rheumatic diseases. Semin. Arthritis Rheum., 15, 231– 254. Clough, J. D. & Calabrese, L. H. (1981). Theoretical aspects of immune complex removal by plasmapheresis. Plasma. Ther. Transfusion Technol., 2, 73– 81. Cohen, R. D., Conn, D. L. & Ilstrup, D. M. (1980). Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin. Proc., 55, 146– 155. Conn, D. L. (1991). Role of cyclophosphamide in treatment of polyarteritis nodosa. J. Rheumatol., 18, 489– 490. Conn, D. L., Tompkins, R. B. & Nichols, W. L. (1988). Glucocorticoids in the management of vasculitis—a double edged sword? J. Rheumatol., 15, 1181– 1183. Costanzo-Nordin, M. R., O'Sullivan, E. J., Hubbell, E. A., Zucker, M. J., Pifarre, R., McManus, B. M., Winters, G. L., Scanlon, P. J. & Robinson, J. A. (1989). Long term follow up of heart transplantation recipients treated with murine antihyman mature T cell monoclonal antibody (OKT3): the Loyola experience. J. Heart Transplant., 8, 288– 295. Crabtree, G. R., Munck, A. & Smith, K. A. (1979). Glucocorticoids inhibit expression of Fc receptors on the human granulocytic cell line, HL-60. Nature, 279, 471– 479. Cupps, T. R. (1990). Cyclophosphamide: To pulse or not to pulse? Am. J. Med., 89, 399– 402. Cupps, T. R., Edgar, L. C. & Fauci, A. C. (1982). Suppression of B lymphocyte function by cyclophosphamide. J. Immunol., 128, 2453– 2457. Cupps, T. R., Edgar, L. L., Thomas, C. A. & Fauci, A. S. (1984). Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. J. Immunol., 132, 170– 175. Damesheck, W. & Schwartz, R. (1960). Treatment of certain ‘autoimmune’ diseases with antimetabolites; a preliminary report. Trans. Ass. Am. Phys., 73, 113– 127. David, D. S., Grieco, M. H. & Cushman, P. (1970). Adrenal glucocorticoids after 20 years. A review of their clinically relevant consequences. J. chronic Dis., 22, 637– 711. Dechant, K. L., Brogden, R. N., Pilkington, T. & Foulds, D. (1991). Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs, 42, 428– 467. Delaney, V. B., Campbell, W. G. Jr. Nasr, S. A., McCue, P., Warshaw, B. & Whelchel, J. D. (1988). Efficacy of OKT3 monoclonal antibody therapy in steroid resistant, predominantly vascular acute rejection. A report of 3 cases with morphologic and immunophenotypic evaluation. Transplantation, 45, 743– 748. Delaney, V. B., Fraley, D. S., Segal, D. P. & Bruns, F. J. (1984). Plasmapheresis as sole therapy in patient with mixed cryoglobulinaemia. Am. J. kidney Dis., 4, 75– 77. Dennis, G., June, C. H., Mizuguchi, J., Ohara, J., Witherspoon, K., Finkleman, F. D., McMillan, V. & Mond, J. J. (1987). Glucocorticoids suppress calcium mobilization and phospholipid hydrolysis in anti-Ig antibody-stimulated B cells. J. Immunol., 139, 2516– 2523. DeRemee, R. A. (1988). The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision? Arthritis Rheum., 31, 1068– 1072. DeRemee, R. A., McDonald, T. J. & Weiland, L. H. (1985). Wegener's granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin. Proc., 60, 27– 32. De Silva, M. & Hazleman, B. (1981). Long-term azathioprine in polymyalgia rheumatica: a double blind study. Ann. Rheum. Dis., 40, 560– 563. de Toledo Codina, J. S., Galindo, C. R., Llop, F. M., Fernandez-Balbuena, C. N. & Lopez, J. G. (1991). Response of central nervous system vasculitis to irradiation. Lancet, 337, 1105– 1106. De Vita, S., Neri, R. & Bombardieri, S. (1991). Cyclophosphamide pulses in the treatment of rheumatic diseases: an update. Clin. exp. Rheumatol., 9, 179– 193. Espinoza, L. R., Espinoza, C. G., Vasey, F. B. & Germain, B. F. (1986). Oral methotrexate therapy for chronic rheumatoid arthritis ulcerations. J. Am. Acad. Dermatol., 15, 508– 512. Exley, A. R., Cohen, A. J. & Buurman, W. (1990). Monoclonal antibody to TNF in severe septic shock. Lancet, 335, 1725– 1726. Fahey, J. L., Leonard, E., Chung, J. & Godman, G. (1954). Wegener's granulomatosis. Am. J. Med., 17, 168– 171. Fauci, A. S. (1976). Mechanisms of corticosteroid action on lymphocyte subpopulations. Clin. exp. Immunol., 24, 54– 62. Fauci, A. S. & Dale, D. C. (1974). The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J. clin. Invest., 53, 240– 246. Fauci, A. S., Haynes, B. F. & Katz, P. (1978). The spectrum of vasculitis: Clinical, pathologic, immunologic and therapeutic considerations. Ann. intern. Med., 89, 660– 676. Fauci, A. S., Haynes, B. F., Costa, J., Katz, P. & Wolff, S. M. (1982). Lymphomatoid granulomatosis. Prospective clinical and therapeutic experience over 10 years. New Engl. J. Med., 306, 68– 74. Fauci, A. S., Haynes, B. F., Katz, P. & Wolff, S. M. (1983). Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients over 21 years. Ann. Intern. Med., 98, 76– 85. Fauci, A. S., Katz, P., Haynes, B. F. & Wolff, S. M. (1979). Cyclophosphamide therapy of severe systemic necrotizing vasculitis. New Engl. J. Med., 301, 235– 238. Felson, D. T. & Andersen, J. (1984). Evidence for the superiority of immunosuppressive drugs and prednisolone over prednisone alone in lupus nephritis: results of a pooled analysis. New Engl. J. Med., 311, 1528– 1533. Fernandez-Herlihy, L. (1980). Duration of corticosteroid therapy in giant cell arteritis. J. Rheumatol., 7, 361– 364. Fondevila-Carlos, G., Milone-Gustavo, A. & Santiago, P. (1989). Cutaneous vasculitis after intermediate dose methotrexate (IDMTX). Br. J. Haematol., 72, 591– 592. Fort, J. G. & Abruzzo, J. L. (1988). Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone. Arthritis Rheum., 31, 1194– 1198. Fortson, J. S., Zone, J. J., Hammond, M. E. & Groggel, G. C. (1986). Hypocomplementaemic urticarial vasculitis syndrome responsive to dapsone. J. Am. Acad. Dermatol., 15, 1137– 1142. Fraga, A., Mintz, G., Valle, L. & Flores-Izquierdo, G. (1972). Takayasu's arteritis: frequency of systemic manifestations (study of 22 patients) and favourable response to maintenance steroid therapy with adrenocorticosteroids (12 patients). Arthritis Rheum., 15, 617– 624. Fredenberg, M. F. & Malkinson, F. D. (1987). Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of 3 cases. J. Am. Acad. Dermatol., 16, 772– 778. Friedman, O. M., Myles, A. & Colvin, M. (1979). Cyclophosphamide and related phosphoramide mustards: current status and future prospects. Adv. Cancer Chemotherapy, 1, 143– 204. Fries, L. F., Brickman, C. M. & Frank, M. M. (1983). Monocyte receptors for the Fc portion of IgG increase in number in autoimmune haemolytic anaemia and other haemolytic states and are decreased by corticosteroid therapy. J. Immunol., 131, 1240– 1245. Frohnert, P. P. & Sheps, S. G. (1967). Long term follow up study of periarteritis nodosa. Am. J. Med., 43, 8– 14. Fuiano, G., Cameron, J. S., Raftery, M., Hartley, B. H., Williams, D. G. & Ogg, C. S. (1988). Improved prognosis of renal microscopic polyarteritis in recent years. Nephrol. Dial. Transplant., 3, 383– 391. Furusho, K., Kamiya, T., Nakana, H., Kiyosawa, N., Shinomiya, K., Hayashidera, T., Tamura, T., Hirose, O., Manabe, Y., Yokoyama, T., Kawarano, M., Baba, K., Baba, K. & Mori, C. (1984). High dose intravenous gammaglobulin for Kawasaki disease. Lancet, ii, 1055– 1058. Galland, R. B. & Spencer, J. (1987). Natural history and surgical management of radiation enteritis. Br. J. Surg., 74, 742– 747. Gassman, A. E. & van Furth, R. (1975). The effect of azathioprine (Imuran) on the kinetics of monocytes and macrophages during the normal steady state and an acute inflammatory reaction. Blood, 46, 51– 64. Geltner, D. (1988). Therapeutic approaches in mixed cryoglobulinaemia. Springer Semin. Immunopathol., 10, 103– 113. Geltner, D., Kohn, R. W., Gorevic, P. & Franklin, E. C. (1981). The effect of combination therapy (steroids, immunosuppressives and plasmapheresis) on 5 mixed cryoglobulinaemia patients with renal, neurologic and vascular involvement. Arthritis Rheum., 24, 1121– 1127. Gillis, S., Crabtree, G. R. & Smith, K. A. (1979). Glucocorticoid induced inhibition of T cell growth factor. J. Immunol., 123, 1632– 1638. Goodwin, J. S. & Atluru, D. (1986). Mechanism of action of glucocorticoid induced immunoglobulin production: role of lipoxygenase metabolites of arachidonic acid. J. Immunol., 136, 3455– 3460. Graham, E., Holland, A., Avery, A. & Russell, R. W. R. (1981). Prognosis in giant cell arteritis. Br. med. J., 282, 269– 271. Gray, R. E. S., Doherty, S. M., Galloway, J., de Broe, M. & Kanis, J. A. (1991). A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis Rheum., 34, 287– 295. Groothuis, D. R. & Mikhael, M. A. (1986). Focal cerebral vasculitis associated with circulating immune complexes and brain irradiation. Ann. Neurol., 19, 590– 592. Guillevin, L., Jarrousse, B., Lok, C., Lhote, F., Jais, J. P., Le Du Thi Huong, D. & Bussel, A. (1991). Long term follow up after treatment of PAN and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma excahge. J. Rheumatol., 18, 567– 574. Hall, S., Barr, W., Stanson, A. W., Kazmier, F. J. & Hunder, G. G. (1985). Takayasu arteritis. A study of 32 North American patients. Medicine, 64, 89– 99. Herrman, F., Schulz, G., Wieser, M., Kolbe, K., Nicolay, U., Noack, M., Lindemann, A. & Mertelsmann, R. (1990). Effect of granulocyte-macrophage colony-stimulating factor on neutropaenia and related morbidity induced by myelotoxic chemotherapy. Am. J. Med., 88, 619– 624. Hirata, F., Schiffman, E., Venkatasubamanian, K., Salomon, D. & Axelrod, J. (1980). A phospholipase inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Natl. Acad. Sci. USA, 77, 2533– 2536. Hoffbrand, B. I. (1991). Dapsone in Henoch-Schonlein purpura—worth a trial. Postgrad. med. J., 67, 961– 962. Hoffman, G. S., Leavitt, R. Y., Fleischer, T. A., Minor, J. R. & Fauci, A. S. (199). Treatment of Wegener's granulomatosis with intermittent high dose intravenous cyclophosphamide. Am. J. Med., 89, 403– 410. Hollander, D. & Manning, R. T. (1967). The use of alkylating agents in the treatment of Wegener's granulomatosis. Ann. intern. Med., 67, 393– 398. Holtman, J. H., Neustadt, D. H., Klein, J. & Callen, J. P. (1990). Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. J. Rheumatol., 17, 1222– 1225. Horneff, G., Burmester, G. R., Emmrich, F. & Kalden, J. R. (1991). Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum., 34, 129– 140. Hunder, G. G. & Lie, J. T. (1983). The vasculitides. Clin. cardiovasc. Dis., 13, 261– 291. Hunder, G. G., Arend, W. P., Bloch, D. A., Calabrese, L. H., Fauci, A. S., Fries, J. F., Leavitt, R. Y., Lie, J. T., Lightfoot, R. W., Masi, A. T., McShane, D. J., Michel, B. A., Mills, J. A., Stevens, M. B., Wallace, S. L. & Zvaifler, N. J. (1990). The American College of Rheumatology 1990 Criteria for the classification of vasculitis: introduction. Arthritis Rheum., 33, 1065– 1067. Hurd, E. R. & Guiliano, V. J. (1975). The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases. Arthritis Rheum., 18, 67– 75. Huskisson, E. C. (1984). Azathioprine. Clin. Rheum. Dis., 10, 325– 332. Irvine, R. F. (1982). How is the level of free arachidonic acid controlled in mammalian cells. Biochem. J., 204, 3– 16. Israel, H. & Patchevsky, A. S. (1975). Treatment of Wegener's granulomatosis of the lung. Am. J. Med., 58, 671– 673. Jayne, D. R. W., Davies, M. J., Fox, C. J. V., Black, C. M. & Lockwood, C. M. (1991). Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet, 337, 1137– 1139. Jeurissen, M. E., Boerbooms, A. M. & van de Putte, L. B. (1989). Eruption of nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Clin. Rheumatol., 8, 417– 419. Joseph, G., Holtman, J. S., Kosfeld, R. E., Blodgett, W. A. & Liu, Y. K. (1987). Pregnancy in Henoch-Schonlein purpura. Am. J. Obstet. Gynecol., 157, 911– 912. Kauffman, R. H. & Houwest, D. A. (1981). Plasmapheresis in rapidly progressive glomerulonephritis and the effect on circulating IgA immune complexes. Clin. Nephrol., 16, 155– 160. Kaveri, S. V., Dietrich, G., Hurez, V. & Kazatchkine, M. D. (1991). Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin. exp. Immunol., 86, 192– 198. Kern, J. A., Laumb, R. J., Reed, J. C., Daniele, R. P. & Nowell, P. C. (1988). Dexamethasone inhibition of interleukin-1 beta production by human monocytes. Post transcriptional mechanisms. J. clin. Invest., 81, 237– 244. Kyle, V. & Hazleman, B. L. (1989a). Treatment of polymyalgia and giant cell erteritis. I. Steroid regimens in the first 2 months. Ann. Rheum. Dis., 48, 658– 661. Kyle, V. & Hazleman, B. L. (1989b). Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid related side effects. Ann. Rheum. Dis., 48, 662– 666. Lanham, J. G., Elkon, K. B., Pusey, C. D. & Hughes, G. R. (1984). Systemic vasculitis with asthma and eosinophilia: A clinical approach to the Churg-Strauss syndrome. Medicine, 63, 65– 81. Leavitt, R. Y. & Fauci, A. S. (1986). Pulmonary vasculitis. Am. Rev. resp. Dis., 134, 149– 166. Leavitt, R. Y., Hoffman, G. S. & Fauci, A. S. (1988). Response: the role of trimethoprim/sulphamethoxazole in the treatment of Wegener's granulomatosis. Arthritis Rheum., 31, 1073– 1074. Leib, E. S., Restivo, C. & Paulus, H. E. (1979). Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am. J. Med., 67, 941– 947. Leung, D. Y. M., Collins, T., Lapierre, L. A., Geha, R. S. & Pober, J. S. (1986). Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated with gamma interferon. J. clin. Invest., 77, 1428– 1435. Levy, J., Barnett, E. V., MacDonald, N. S., Klinenberg, J. R. & Pearson, C. M. (1972). The effect of azathioprine on gammaglobulin synthesis in man. J. clin. Invest., 51, 2233– 2238. Liebow, A. A., Carrington, C. R. B. & Friedman, P. J. (1972). Lymphomatoid granulomatosis. Hum. Pathol., 3, 457– 000. Locht, H. & Lindstrom, F. D. (1989). Wegener's granulomatosis. Treatment failure on conventional treatment. J. Rheumatol., 16, 544– 546. Lockwood, C. M., Pinching, A. J., Sweny, P., Rees, A. J., Pussel, B. & Uff, J. (1977). Plasma-exchange and immunosuppression in the treatment of fulminating immune complex crescentic glomerulonephritis. Lancet, I, 63– 67. Low, A., Hotze, A., Krapf, F., Schranz, W., Manger, B. J., Mahlstedt, J. & Wolf, F. (1985). The non-specific clearance function of the reticuloendothelial system in patients with immune complex mediated diseases before and after therapeutic plasmapheresis. Rheumatol. Int., 5, 69– 72. Lupi-Herrera, E., Sanchez-Torres, G., Marcushamer, J., Mispirita, J., Horwitz, S. & Vela, J. E. (1977). Takayasu's arteritis: clinical study of 107 cases. Am. Heart J., 93, 94– 103. Luqmani, R. A., Palmer, R. G. & Bacon, P. A. (1990). Axzathioprine, cyclophosphamide and chlorambucil. Balliere's Clin. Rheumatol., 4, 595– 619. MacFadyen, R., Tron, V., Keshmiri, M. & Road, J. D. (1987). Allergic angitis of Churg and Strauss syndrome. Response to pulse methylprednisolone. Chest, 91, 629– 631. MacGregor, R. R. (1977). Granulocyte adherence changes induced by haemodialysis, endotoxin, epinephrine and glucocorticoids. Ann. Intern. Med., 86, 35– 39. Maddocks, J. L. (1978). Clinical pharmacological observations on azathioprine in kidney transplant patients. Clin. Sci. mol. Med., 55, 20p. Manger, B. J., Krapf, F. E., Gramatski, M., Nusslein, H. G., Burmester, G. R., Krauledat, P. B. & Kalden, J. R. (1985). IgE containing circulating immune complexes in Churg-Strauss vasculitis. Scand. J. Immunol., 21, 369– 373. Mathieson, P. W., Cobbold, P. S., Hale, G., Clark, M. R., Oliviera, D. B., Lockwood, C. M. & Waldmann, H. (1990). Monoclonal antibody therapy in systemic vasculitis. New Engl. J. Med., 323, 250– 254. Mouridsen, H. T. & Jacobsen, E. (1975). Pharmacokinetics of cyclophosphamide in renal failure. Acta Pharmac. Tox., 36, 409– 414. Navarro, M., Pedragosa, R., Lafuerza, A., Rubio, D. & Huguet, P. (1986). Leukocytoclastic vasculitis after high dose methotrexate. Ann. intern. Med., 105, 471– 472. Newberger, J. W., Takahashi, M., Beiser, A. S., Burns, J. C., Bastian, J., Chung, K. J., Colan, S. D., Duffy, C. E., Fulton, D. R., Glode, M. P., Mason, W. H., Meissner, H. C., Rowley, A. H., Shulman, S. T., Reddy, V., Sundel, R. P., Wiggins, J. W., Colton, T., Melish, M. E. & Rosen, F. S. (1991). A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. New Engl. J. Med., 324, 1633– 1639. Newburger, J. W., Takahashi, M., Burns, J. C., Beiser, A. S., Chung, K. J., Duffy, C. E., Glode, M. P., Mason, W. H., Reddy, V., Sanders, S. P., Shulman, S. T., Wiggins, J. W., Hicks, R. V., Fulton, D. R., Lewis, A. B., Leung, D. Y. M., Colton, T., Rosen, F. S. & Melish, M. E. (1986). The treatment of Kawasaki syndrome with intravenous gamma globulin. New Engl. J. Med., 315, 341– 347. Nicholls, A., Snaith, M. L., Maini, R. N. & Scott, J. T. (1973). Controlled trial of azathioprine in rheumatoid vasculitis. Ann. Rheum. Dis., 32, 589– 591. Novack, S. N. & Pearson, C. M. (1971). Cyclophosphamide therapy in Wegener's granulomatosis. New Engl. J. Med., 284, 938– 942. O'Duffy, T. D., Robertson, D. M. & Goldstein, N. P. (1984). Chlorambucil in the treatment of uveitis and meningoencephalitis of Behcet's disease. Am. J. Med., 76, 75– 84. O'Meara, Y., Cameron, J. S., Raftery, M., Hartley, B. H., Williams, D. G. and Ogg, C. S. (1989). Improved prognosis of renal microscopic polyarteritis in recent years. Nephrol. Dial. Transplant., 3, 383– 391. Oster, W., Hermann, F., Cicco, A., Gamm, H., Zeile, G., Brune, T., Lindemann, A., Schulz, G. & Mertelsmann, R. (1990). Erythropoietin prevents chemotherapy induced anaemia: case report. Blut, 60, 88– 92. Paavonen, T. (1982). Glucocorticoids enhance the in vitro Ig synthesis of pokeweed mitogen-stimulated human B-cells by inhibiting the suppressive effect of T8 + T cells. Scand. J. Immunol., 21, 63– 71. Parillo, J. E. & Fauci, A. S. (1979). Mechanisms of glucocorticoid action on immune processes. Ann. Rev. Pharmac. Tox., 19, 179– 201. Petersen, J. (1985). Essential cryoglobulinaemia: a clinical course lasting 25 years. Scand. J. Haematol., 35, 501– 504. Petru, E. & Schmahl, D. (1987). Second malignancies—risk reduction. Cancer Treat. Rev., 14, 337– 343. Pinching, A. J., Rees, A. J., Pusell, B. A., Lockwood, C. M., Mitchison, R. S. & Peters, D. K. (1980). Relapses in Wegener's granulomatosis: the role of infection. Br. med. J., 281, 836– 838. Plotnick, S., Huppert, A. S. & Kantor, G. (1989). Colchicine and leukocytoclastic vasculitis. Arthritis Rheum., 32, 1489– 1490. Reichmann, L., Clark, M., Waldmann, H. & Winter, G. (1988). Reshaping human antibodies for therapy. Nature, 332, 323– 327. Report to the Medical Research Council by the Collagen Diseases and Hypersensitivity Panel (1960). Treatment of polyarteritis nodosa with cortisone: results after 3 years. Br. med. J., 1, 1399– 1400. Rinehart, J. J., Sagone, A. L., Balcerzak, S. P., Ackerman, G. A. & LoBuglio, A. L. (1975). Effects of corticosteroid therapy on human monocyte function. New Engl. J. Med., 292, 236– 241. Sakamoto, H., Takaoka, T., Usami, M., Emura, M., Okabe, K., Matsushita, M., Smith, J. W., Malchesky, P. S. & Nose, Y. (1985). Apheresis: clinical response of patients unresponsive to conventional therapy. Trans. Am. Soc. Artif. Intern. Organs, 31, 704– 710. Schlansky, R., Dehoratius, R. J., Pincus, T. & Tung, K. S. (1981). Plasmapheresis in systemic lupus erythematosis: A cautionary note. Arthritis Rheum., 24, 49– 53. Schneider, H. A., Yonker, R. A., Katz, P., Longley, S. & Panush, R. S. (1985). Rheumatoid vasculitis: experience with 13 patients and review of the literature. Semin. Arthritis Rheum., 14, 280– 286. Schriber, A. D., Parson, J., McDermott, P. & Cooper, R. A. (1975). Effect of corticosteroids on the human monocyte IgG and complement receptors. J. clin. Invest., 56, 1189– 1197. Scott, D. G. I. & Bacon, P. A. (1984). Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am. J. Med., 76, 377– 384. Scott, D. G. I., Bacon, P. A., Elliott, P. J., Tribe, C. R. & Wallington, T. B. (1982). Systemic vasculitis in a District General Hospital: Clinical and laboratory features, classification and prognosis of 80 cases. Quart. J. Med., 203, 292– 311. Segal, R., Caspi, D., Tishler, M., Fishel, B. & Yaron, M. (1988). Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum., 31, 1182– 1185. Shaw, I. C. & Graham, M. I. (1978). Mesna—a short review. Cancer Treat. Rev., 14, 67– 86. Shelhamer, J. H., Volkman, D. J., Parillo, J. E., Lawley, T. J., Johnston, M. R. & Fauci, A. S. (1985). Takayasu's arteritis and its therapy. Ann. Intern. Med., 103, 121– 126. Sladek, N. E. (1972). Therapeutic efficacy of cyclophosphamide as a function of its metabolism. Cancer Res., 32, 535– 542. Smith, K. A. (1980). T cell growth factor. Immunol. Rev., 51, 337– 357. Spann, C. R., Callen, J. P., Yam, L. T. & Apgar, J. T. (1986). Cutaneous leukocytoclastic vasculitis complicating hairy cell leukaemia (leukaemic reticuloendotheliosis). Arch. Dermatol., 122, 1057– 1059. Sultan, Y., Kazatchkine, M. D., Maisoneuve, P. & Nyedeggar, U. E. (1984). Anti-idiotype suppression of autoantibodies to factor VIII by high dose intravenous immunoglobulin. Lancet, ii, 765– 768. Tabbara, K. F. (1983). Chlorambucil in Behcet's disease: a reappraisal. Opthalmology, 90, 906– 908. Tidd, D. M. & Paterson, A. R. P. (1974). A biochemical mechanism for the delayed cytotoxic reaction of 6 M-P. Cancer Res., 34, 738– 746. Turk, J. L. & Poulter, L. W. (1972). Selective depletion of lymphoid tissue by cyclophosphamide. Clin. exp. Immunol., 10, 285– 296. Upchurch, K. S., Heller, K. & Bress, N. M. (1987). Low dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis. J. Am. Acad. Dermatol., 17, 355– 359. Walton, E. W. (1958). Giant cell granuloma of the respiratory tract (Wegener's granulomatosis). Br. med. J., ii, 265– 270. Ware, A. J., Luby, J. P., Hollinger, B., Eigenbrodt, E. H., Cuthbert, J. A., Atkins, C. R., Shorey, J., Hull, A. R. & Combes, B. (1979). Etiology of liver disease in renal transplant patients. Ann. intern. Med., 91, 364– 371. Werni, R., Schwartz, T. & Geschnait, F. (1986). Colchicine treatment of urticarial vasculitis. Dermatologica, 172, 36– 40. West, B. C., Todd, J. R. & King, J. W. (1987). Wegener's granulomatosis and trimethoprim-sulphamethoxazole: complete remission after a twenty year course. Ann. intern. Med., 106, 840– 842. Weusten, B. L. A. M., Jacobs, J. W. G. & Bijlsma, J. W. J. (1992). Complications of corticosteroid pulse therapy in rheumatoid arthritis. Br. J. Rheumatol., 31 (Suppl. 2), 125. Williams, H. C. & Pembroke, A. C. (1989). Methotrexate in the treatment of vasculitic cutaneous ulceration in rheumatoid arthritis. J. Roy. Soc. Med., 82, 763. Winklestein, A., Starz, T. W. & Agarwal, A. (1984). Efficacy of combined therapy with plasmapheresis and immunosuppressants in rheumatoid vasculitis. J. Rheumatol., 11, 162– 166. Wofsy, D., Chiang, N. Y., Greenspan, J. S. & Ermak, T. H. (1988). Treatment of murine lupus with monoclonal antibody to L3T4. I. Effects of the distribution and function of lymphocyte subsets and on the histopathology of autoimmune disease. J. Autoimmun., 1, 415– 431. Wolff, S. M., Fauci, A. S., Horn, R. G. & Dale, D. C. (1974). Wegener's granulomatosis. Ann. intern. Med., 81, 513– 525. Wysenbeek, A. J., Calabrese, L. H., Mandel, D. R. & Clough, J. D. (1982). Limited plasmapheresis in fulminant leukocytoclastic vasculitis. J. Rheumatol., 9, 315– 318. Yazici, H., Pazarali, H., Barnes, C. G., Tugun, Y., Silman, A., Serdaroglu, S., Oguz, V., Yurdakal, S., Lovatt, G. E., Yazici, B., Somani, S. & Muftuoglu, A. (1990). A controlled trial of azathioprine in Behcet's syndrome. New Engl. J. Med., 322, 281– 285. Yu, D. T., Clements, P. J., Peter, J. B., Levy, J., Paulus, H. E., Barnett, E. V. (1974). Lymphocyte characteristics in rheumatic patients and the effect of azathioprine therapy. Arthritis Rheum., 17, 37– 45. Yuasa, K., Tokitsu, M., Goto, H., Kato, H. & Shimada, K. (1988). Wegener's granulomatosis: diagnosis by transbronchial biopsy, evaluation by gallium scintigraphy and treatment with sulphamethoxazole/trimethoprim. Am. J. Med., 84, 371– 372. Zeek, P. M. (1952). Periarteritis nodosa: a critical review. Am. J. clin. Path., 22, 777– 790. Zhu, L. P., Cupps, T. R., Whalen, G. & Fauci, A. S. (1987). Selective effects of cyclophosphamide therapy on activation, proliferation and differentiation of human B-cells. J. clin. Invest., 79, 1082– 1090. Ziegler, E. J., Fisher, C. J., Sprung, C. L., Straube, R. C., Sadoff, J. C., Foulke, G. E., Wortel, C. H., Fink, M. P., Dillinger, R. P., Teng, N. N. H., Allen, I.E., Berger, H. J., Knatterud, G. L., LoBuglio, A. F., Smith, C. R. & the HA-IA Sepsis Study Group (1991). Treatment of Gram negative bacteraemia and septic shock with HA-IA human monoclonal antibody against endotoxin. New Engl. J. Med., 324, 430– 436. Citing Literature Volume35, Issue2Feb 1993Pages 93-104 ReferencesRelatedInformation
Referência(s)